Doença meningocócica

Centers for Disease Control and Prevention. Meningococcal disease. Feb 2024 [internet publication].Full text

Mbaeyi SA, Bozio CH, Duffy J, et al; Centers for Disease Control and Prevention. Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020 Sep 25;69(9):1-41.Full text  Abstract

van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22 Suppl 3:S37-62.Full text  Abstract

1. Rubis A, Schillie S. Chapter 8: meningococcal disease. Manual for the surveillance of vaccine-preventable diseases. Atlanta, GA: Centers for Disease Control and Prevention; 2024.

2. Pollard AJ. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J. 2004 Dec;23(suppl 12):S274-9. Abstract

3. Rodgers E, Bentley SD, Borrow R, et al. The global meningitis genome partnership. J Infect. 2020 Oct;81(4):510-20.Full text  Abstract

4. Mbaeyi S, Duffy J, McNamara L A. Chapter 14: meningococcal disease. Epidemiology and prevention of vaccine-preventable diseases. 14th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2024.

5. Klein JO. Management of the febrile child without a focus of infection in the era of universal pneumococcal immunization. Pediatr Infect Dis J. 2002 Jun;21(6):584-8;discussion 613-4. Abstract

6. Lefèvre B, Poinsignon Y, Piau C, et al; Groupe d’Epidémiologie et Recherche en Infectiologie Clinique du Centre et de l’Ouest (GERICCO). Chronic meningococcemia: a report of 26 cases and literature review. Infection. 2019 Apr;47(2):285-8. Abstract

7. Centers for Disease Control and Prevention. Meningococcal disease in other countries. Feb 2024 [internet publication].Full text

8. European Centre for Disease Prevention and Control. Invasive meningococcal disease - annual epidemiological report for 2018. Jun 2022 [internet publication].Full text

9. World Health Organization. Emergence of W135 meningococcal disease. Report of a WHO consultation, Geneva 17-18 September 2001. Geneva: World Health Organization; 2002.Full text

10. Centers for Disease Control and Prevention. Meningococcal disease: meningococcal disease surveillance and trends. May 2025 [internet publication].Full text

11. MacNeil JR, Blain AE, Wang X, et al. Current epidemiology and trends in meningococcal disease - United States, 1996-2015. Clin Infect Dis. 2018 Apr 3;66(8):1276-81.Full text  Abstract

12. Moore AE, MacNeil JR, Wang X, et al. Emergence of localized serogroup W meningococcal disease in the United States - Georgia, 2006-2016. MMWR Morb Mortal Wkly Rep. 2018 Aug 17;67(32):894-7.Full text  Abstract

13. Rosenstein NE, Perkins BA, Stephens DS, et al. Meningococcal disease. N Engl J Med. 2001 May 3;344(18):1378-88. Abstract

14. Musher DM. How contagious are common respiratory tract infections? N Engl J Med. 2003 Mar 27;348(13):1256-66. Abstract

15. Caugant DA, Tzanakaki G, Kriz P. Lessons from meningococcal carriage studies. FEMS Microbiol Rev. 2007 Jan;31(1):52-63.Full text  Abstract

16. Christensen H, May M, Bowen L, et al. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010 Dec;10(12):853-61. Abstract

17. Maiden MC, Bygraves JA, Feil E, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3140-5.Full text  Abstract

18. Tzeng YL, Stephens DS. Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect. 2000 May;2(6):687-700. Abstract

19. Waage A, Brandtzaeg P, Halstensen A, et al. The complex pattern of cytokines in serum from patients with meningococcal septic shock: association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med. 1989 Jan 1;169(1):333-8.Full text  Abstract

20. Brandtzaeg P, Kierulf P, Gaustad P, et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis. 1989 Feb;159(2):195-204. Abstract

21. Centers for Disease Control and Prevention. Meningococcal disease. Feb 2024 [internet publication].Full text

22. Mbaeyi SA, Bozio CH, Duffy J, et al; Centers for Disease Control and Prevention. Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020 Sep 25;69(9):1-41.Full text  Abstract

23. Neal KR, Nguyen-Van-Tam JS, Jeffrey N, et al. Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study. BMJ. 2000 Mar 25;320(7238):846-9.Full text  Abstract

24. Fijen CA, Kuijper EJ, te Bulte MT, et al. Assessment of complement deficiency in patients with meningococcal disease in the Netherlands. Clin Infect Dis. 1999 Jan;28(1):98-105.Full text  Abstract

25. McNamara LA, Topaz N, Wang X, et al. High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine. MMWR Morb Mortal Wkly Rep. 2017 Jul 14;66(27):734-7.Full text  Abstract

26. Centers for Disease Control and Prevention. Meningococcal disease: risk factors for meningococcal disease. Feb 2024 [internet publication].Full text

27. Miller L, Arakaki L, Ramautar A, et al. Elevated risk for invasive meningococcal disease among persons with HIV. Ann Intern Med. 2014 Jan 7;160(1):30-7. Abstract

28. Folaranmi TA, Kretz CB, Kamiya H, et al. Increased risk for meningococcal disease among men who have sex with men in the United States, 2012-2015. Clin Infect Dis. 2017 Sep 1;65(5):756-63.Full text  Abstract

29. Dubey H, Oster P, Fazeli MS, et al. Risk factors for contracting invasive meningococcal disease and related mortality: a systematic literature review and meta-analysis. Int J Infect Dis. 2022 Jun;119:1-9.Full text  Abstract

30. Lee GM. Preventing infections in children and adults with asplenia. Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):328-35.Full text  Abstract

31. Mbaeyi SA, Joseph SJ, Blain A, et al. Meningococcal disease among college-aged young adults: 2014-2016. Pediatrics. 2019 Jan;143(1):e20182130. [Erratum in: Pediatrics. 2019 May;143(5):e20190342.]Full text  Abstract

32. Mandal S, Campbell H, Ribeiro S, et al. Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine. Vaccine. 2017 Oct 13;35(43):5814-8. Abstract

33. Bruce MG, Rosenstein NE, Capparella JM, et al. Risk factors for meningococcal disease in college students. JAMA. 2001 Aug 8;286(6):688-93.Full text  Abstract

34. Centers for Disease Control and Prevention. Infection control in healthcare personnel: epidemiology and control of selected infections. Jan 2025 [internet publication].Full text

35. Martín-Sánchez M, Fairley CK, Bradshaw CS, et al. Meningococcal vaccine uptake among men who have sex with men in response to an invasive meningococcal C disease outbreak in Melbourne, Australia. Sex Transm Infect. 2020 Jun;96(4):246-50.Full text  Abstract

36. Centers for Disease Control and Prevention: CDC Newsroom. CDC assists with meningococcal disease outbreak investigation in Florida. Jun 2022 [internet publication].Full text

37. Centers for Disease Control and Prevention. ACIP recommendations: meningococcal vaccine. Jul 2024 [internet publication].Full text

38. Ghia CJ, Rambhad GS. Meningococcal disease burden in India: a systematic review and meta-analysis. Microbiol Insights. 2021 Nov 29;14:11786361211053344.Full text  Abstract

39. Sejvar JJ, Johnson D, Popovic T, et al. Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol. 2005 Sep;43(9):4811-4.Full text  Abstract

40. Fischer M, Hedberg K, Cardosi P, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J. 1997 Oct;16(10):979-83. Abstract

41. Moore PS, Hierholzer J, DeWitt W, et al. Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA. 1990 Sep 12;264(10):1271-5. Abstract

42. Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006 Feb 4;367(9508):397-403. Abstract

43. MacLennan J, Kafatos G, Neal K, et al; United Kingdom Meningococcal Carriage Group. Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis. 2006 Jun;12(6):950-7.Full text  Abstract

44. Mbaeyi S, Pondo T, Blain A, et al. Incidence of meningococcal disease before and after implementation of quadrivalent meningococcal conjugate vaccine in the United States. JAMA Pediatr. 2020 Sep 1;174(9):843-51.Full text  Abstract

45. World Health Organization. WHO recommendations for routine immunization - summary tables. Dec 2024 [internet publication].Full text

46. American Academy of Pediatrics. ​Patient care: immunizations. Jan 2025 [internet publication].Full text

47. Curtis S, Stobart K, Vandermeer B, et al. Clinical features suggestive of meningitis in children: a systematic review of prospective data. Pediatrics. 2010 Nov;126(5):952-60. Abstract

48. National Institute for Health and Care Excellence. Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management. Mar 2024 [internet publication].Full text

49. McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38.Full text  Abstract

50. Heckenberg SGB, de Gans J, Brouwer MC, et al. Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore). 2008 Jul;87(4):185-92.Full text  Abstract

51. American Academy of Pediatrics. Meningococcal infections. In: Kimberlin DW, Banerjee R, Barnett ED, et al, eds. Red Book: 2024-2027 report of the Committee on Infectious Diseases. 33rd ed. Itasca, IL: American Academy of Pediatrics; 2024:585-99.

52. Nadel S, Kroll JS. Diagnosis and management of meningococcal disease: the need for centralized care. FEMS Microbiol Rev. 2007 Jan;31(1):71-83.Full text  Abstract

53. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004 Oct 28;351(18):1849-59.Full text  Abstract

54. Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010 July;23(3):467-92.Full text  Abstract

55. van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016 May;22 Suppl 3:S37-62.Full text  Abstract

56. Bryant PA, Li HY, Zaia A, et al. Prospective study of a real-time PCR that is highly sensitive, specific, and clinically useful for diagnosis of meningococcal disease in children. J Clin Microbiol. 2004 Jul;42(7):2919-25.Full text  Abstract

57. Schuurman T, de Boer RF, Kooistra-Smid AM, et al. Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting. J Clin Microbiol. 2004 Feb;42(2):734-40.Full text  Abstract

58. ​Centers for Disease Control and Prevention. Meningococcal disease: best practice guidelines for diagnosis of Haemophilus influenzae and Neisseria meningitidis disease. Aug 2024 [internet publication].Full text

59. Trujillo-Gómez J, Tsokani S, Arango-Ferreira C, et al. Biofire FilmArray Meningitis/Encephalitis Panel for the aetiological diagnosis of central nervous system infections: a systematic review and diagnostic test accuracy meta-analysis. EClinicalMedicine. 2022 Feb;44:101275.Full text  Abstract

60. Rajbhandari P, Goodrich N, Nabower AM, et al. Current state and practice variation in the use of Meningitis/Encephalitis (ME) FilmArray panel in children. BMC Infect Dis. 2022 Oct 31;22(1):811.Full text  Abstract

61. Sundelin T, Bialas J, de Diego J, et al. Evaluation of the QIAstat-Dx Meningitis/Encephalitis Panel, a multiplex PCR platform for the detection of community-acquired meningoencephalitis. J Clin Microbiol. 2023 Oct 24;61(10):e0042623.Full text  Abstract

62. Straus SE, Thorpe KE, Holroyd-Leduc J. How do I perform a lumbar puncture and analyze the results to diagnose bacterial meningitis? JAMA. 2006 Oct 25;296(16):2012-22.Full text  Abstract

63. Rennick G, Shann F, de Campo J. Cerebral herniation during bacterial meningitis in children. BMJ. 1993 Apr 10;306(6883):953-5.Full text  Abstract

64. Viallon A, Botelho-Nevers E, Zeni F. Clinical decision rules for acute bacterial meningitis: current insights. Open Access Emerg Med. 2016 Apr 19;8:7-16.Full text  Abstract

65. Le Saux N; Canadian Pediatric Society. Position statement: guidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than 2 months of age. Oct 2020 [internet publication].Full text

66. Hasbun R. Progress and challenges in bacterial meningitis: a review. JAMA. 2022 Dec 6;328(21):2147-54. Abstract

67. Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59.Full text  Abstract

68. Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;(9):CD004405.Full text  Abstract

69. van de Beek D, Farrar JJ, de Gans J, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol. 2010 Mar;9(3):254-63. Abstract

70. Mount HR, Boyle SD. Aseptic and bacterial meningitis: evaluation, treatment, and prevention. Am Fam Physician. 2017 Sep 1;96(5):314-22.Full text  Abstract

71. Ramirez D, Nigo M, Hasbun R, et al. Timing and use of adjunctive steroids in adults with bacterial meningitis: compliance with international guidelines. Open Forum Infect Dis. 2022 Dec15; 9(2):877.Full text

72. Gilbert DN, Chambers HF, Saag MS, et al, eds. The Sanford guide to antimicrobial therapy 2022. 52nd ed. Sperryville, VA: Antimicrobial Therapy, Inc; 2022.

73. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.Full text  Abstract

74. Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020 Feb;46(suppl 1):10-67.Full text  Abstract

75. Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet. 2003 Jun 21;361(9375):2139-48. Abstract

76. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 Nov 1;39(9):1267-84.Full text  Abstract

77. Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3):804.Full text  Abstract

78. Potts CC, Rodriguez-Rivera LD, Retchless AC, et al. Antimicrobial susceptibility survey of invasive Neisseria meningitidis, United States 2012-2016. J Infect Dis. 2022 Jun 1;225(11):1871-5.Full text  Abstract

79. Alderson MR, Arkwright PD, Bai X, et al; GMI Collaborators. Surveillance and control of meningococcal disease in the COVID-19 era: a Global Meningococcal Initiative review. J Infect. 2022 Mar;84(3):289-96.Full text  Abstract

80. Mace SE. Acute bacterial meningitis. Emerg Med Clin North Am. 2008 May;26(2):281-317, viii. Abstract

81. World Health ​Organization. WHO guidelines on meningitis diagnosis, treatment and care. Apr 2025 [internet publication].Full text

82. Preziosi MP, Greenwood B. NmCV-5 meningococcal vaccine: Neisseria meningitidis' nemesis? Lancet Infect Dis. 2018 Oct;18(10):1049-50. Abstract

83. Haidara FC, Umesi A, Sow SO, et al. Meningococcal ACWYX conjugate vaccine in 2-to-29-year-olds in Mali and Gambia. N Engl J Med. 2023 May 25;388(21):1942-55.Full text  Abstract

84. Sherman AC, Stephens DS. Serogroup A meningococcal conjugate vaccines: building sustainable and equitable vaccine strategies. Expert Rev Vaccines. 2020 May;19(5):455-63.Full text  Abstract

85. Ukoaka BM, Okesanya OJ, Daniel FM, et al. A perspective on the novel pentavalent Men5CV (NmCV-5) meningitis vaccine and Nigeria's pioneering rollout campaign. Infez Med. 2024 Sep 1;32(3):323-9.Full text  Abstract

86. El-Hajj VG, Pettersson I, Gharios M, et al. Detection and management of elevated intracranial pressure in the treatment of acute community-acquired bacterial meningitis: a systematic review. Neurocrit Care. 2024 Aug;41(1):228-43.Full text  Abstract

87. Brooks R, Woods CW, Benjamin DK Jr., et al. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Clin Infect Dis. 2006 Jul 1;43(1):49-54.Full text  Abstract

88. Zalmanovici Trestioreanu A, Fraser A, Gafter-Gvili A, et al. Antibiotics for preventing meningococcal infections. Cochrane Database Syst Rev. 2013 Oct 25;(10):CD004785.Full text  Abstract

89. Public Health Agency of Canada. Canadian immunization guide part 4 - immunizing agents: meningococcal vaccines. Aug 2025 [internet publication].Full text

90. Goldstein EJC, Overturf GD. Indications for the immunological evaluation of patients with meningitis. Clin Infect Dis. 2003 Jan 15;36(2):189-94.Full text  Abstract

91. Platonov AE, Vershinina IV, Kuijper EJ, et al. Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine. Vaccine. 2003 Oct 1;21(27-30):4437-47. Abstract